Cargando…

The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery

BACKGROUNDS: Prognostic factors are defined as biological or clinical measurement associated with overall survival and/or disease-free survival. Previous studies have shown that patients with estrogen receptor (ER) positive cancers have a better prognosis than patients whose cancers do not have thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiba, Takayoshi, Inamoto, Takashi, Nishimura, Tsutomu, Ueno, Masaya, Yanagihara, Kazuhiro, Teramukai, Satoshi, Kato, Hironori, Toi, Masakazu, Fukushima, Masanori
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585098/ https://www.ncbi.nlm.nih.gov/pubmed/18990247 http://dx.doi.org/10.1186/1471-2407-8-323

Ejemplares similares

Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma
por: Tada, Harue, et al.
Publicado: (2009)

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02
por: Nakagawa, Masatsugu, et al.
Publicado: (2009)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model
por: Takada, Masahiro, et al.
Publicado: (2012)

Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023)

Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer
por: Hu, Jiejie, et al.
Publicado: (2021)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures
por: Nishimura, Tsutomu, et al.
Publicado: (2006)

Axillary lymph node dissection for breast cancer utilizing Harmonic Focus(®)
por: Ostapoff, Katherine T, et al.
Publicado: (2011)

Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection
por: Santivasi, Wil L., et al.
Publicado: (2014)

Axillary Lymph Node Dissection in Angiosarcomas of the Breast: An Asian Institutional Perspective
por: Ragavan, Sharanniyan, et al.
Publicado: (2020)

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Indo-cyanine green administration to identify loss of lymph after axillary lymph node dissection
por: Roman, Mirela Mariana, et al.
Publicado: (2023)

Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection
por: Wu, Jun‐Dong, et al.
Publicado: (2020)

200 Sentinel lymph node biopsies without axillary lymph node dissection – no axillary recurrences after a 3-year follow-up
por: Reitsamer, R, et al.
Publicado: (2004)

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
por: Sarri, Almir José, et al.
Publicado: (2017)

Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients
por: Soares, Emerson Wander Silva, et al.
Publicado: (2014)

Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries
por: Abass, Mohaned O., et al.
Publicado: (2018)

Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
por: Yuan, Qianqian, et al.
Publicado: (2021)

Axillary Reverse Mapping in Patients Undergoing Axillary Lymph Node Dissection: A Single Institution Experience From India
por: Jena, Sanghamitra, et al.
Publicado: (2021)

Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation
por: Hirata, Kimiko, et al.
Publicado: (2017)

Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
por: TAKAMARU, TOMOKO, et al.
Publicado: (2014)

Prognostic significance of lymph node dissection for lung cancer surgery: a narrative review
por: Ichiki, Yoshinobu, et al.
Publicado: (2023)

10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection
por: Campbell, Ian, et al.
Publicado: (2023)

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes
por: Ishida, Takanori, et al.
Publicado: (2008)

Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients
por: Ikeda, Katsumi, et al.
Publicado: (2012)

Vascularized Free Lymph Node Flap Transfer in Advanced Lymphedema Patient after Axillary Lymph Node Dissection
por: Cook, Kyung Hoon, et al.
Publicado: (2016)

The application of methylene blue coloration technique in axillary lymph node dissection of breast cancer
por: Zou, Jieya, et al.
Publicado: (2019)

Prophylactic Lymphovenous Bypass at the Time of Axillary Lymph Node Dissection Decreases Rates of Lymphedema
por: Deldar, Romina, et al.
Publicado: (2023)

Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study
por: Mokbel, Kefah, et al.
Publicado: (2023)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
por: Lee, Jina, et al.
Publicado: (2018)

Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
por: Kim, Bong Kyun, et al.
Publicado: (2020)

Axillary lymph node dissection combined with radiotherapy for trichilemmal carcinoma with giant lymph node metastasis: A case report
por: Lv, Wenjie, et al.
Publicado: (2022)

From Cadaveric Dissection to the Operating Room: A Unilateral Double Intercostobrachial Nerve and the Implications in Axillary Lymph Node Dissection
por: Olivencia-Delgado, Mariana N, et al.
Publicado: (2023)

Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Axillary surgery in the case of limited involved axillary lymph nodes
por: Kolberg, Hans-Christian, et al.
Publicado: (2023)

Intercostobrachial Nerves as a Novel Anatomic Landmark for Dividing the Axillary Space in Lymph Node Dissection
por: Li, Jianyi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l4d3knthcrstsej7dsb9q33etd